Related Experiment Videos
Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing
Liqin Zhao1, Kathleen O'Neill, Roberta Diaz Brinton
1Department of Molecular Pharmacology and Toxicology and the Program in Neuroscience, School of Pharmacy, University of Southern California, Pharmaceutical Sciences Center, Los Angeles, CA 90089, USA.
Brain Research. Brain Research Reviews
|November 5, 2005
Summary
Developing novel neuroestrogen selective estrogen receptor modulators (NeuroSERMs) offers a promising strategy to enhance brain health and prevent neurodegenerative diseases. These targeted therapies aim to improve memory and neuronal survival while minimizing risks associated with traditional estrogen therapies.
Area of Science:
- Neuroscience
- Endocrinology
- Pharmacology
Background:
- Efficacy of estrogen action in the brain presents unresolved challenges, including optimal therapy timing, formulation, and duration.
- Thrombotic and neoplastic risks necessitate careful consideration in developing estrogen alternatives for neurodegenerative disorders and climacteric symptoms.
- Selective targeting of brain estrogen mechanisms is crucial to avoid peripheral side effects, particularly in reproductive organs.
Purpose of the Study:
- To review recent advances in estrogen action mechanisms for designing effective Neuro-SERMs.
- To explore strategies for developing molecules that promote memory function and neuronal survival.
- To identify novel approaches for preventing brain-related climacteric symptoms and neurodegenerative diseases.
Main Methods:
- Overview of molecular mechanisms of estrogen action.
- Pharmacological analysis of estrogen receptor subtypes.
- Evaluation of existing selective estrogen receptor modulators (SERMs) in neurons.
Main Results:
- Insights into designing efficacious NeuroSERMs that activate specific cellular, biochemical, and genomic events in the brain.
- Understanding the role of estrogen receptor subtypes and a potential membrane-associated splice variant in mediating estrogenic effects.
- Identification of strategies for developing novel molecules with NeuroSERM potential.
Conclusions:
- Novel molecules with NeuroSERM potential can be developed to selectively target brain estrogen mechanisms.
- These targeted therapies may prevent brain-related climacteric symptoms and neurodegenerative diseases.
- Further research into selective estrogen receptor modulation is vital for brain health.